Logo
Login
$MLYS
$20.56 +$0.01 (0.05%) Close

Company Executives

$MLYS Management Team

Mr. Glenn Sblendorio

Non-Executive Independent Chairman of the Board

Age 69
Compensation $251.9K USD
Sex Male

Mr. Jon Congleton

Chief Executive Officer

Director

Age 61
Compensation $5.421M USD
Sex Male

Dr. Brian Slingsby

Founder

Independent Director

Age 48
Compensation $275.3K USD
Sex Male

Mr. Adam Levy

Chief Financial Officer

Company Secretary

Age 46
Compensation $2.849M USD
Sex Male

Dr. David Rodman

Chief Medical Officer

Age 69
Compensation $2.878M USD
Sex Male

Board of Directors

From the proxy statement filed Apr 8, 2026
Directors
7
serving now
Independent
6 of 6
stated in the proxy; 1 not stated
Average tenure
4.3 years
from year joined
CEO also chairs the board
No
Glenn P. Sblendorio
Director Age On board Independent Committees Other public boards 2025 pay Source
Brian Taylor Slingsby
49 2019
7 years
 Independent
Compensation Committee Nominating and Corporate Governance Committee · Chair
None stated Not stated
Srinivas Akkaraju
58 2021
5 years
 Independent
Nominating and Corporate Governance Committee
vTv Therapeutics Inc., Alumis Inc., Inventiva S.A. Not stated
Daphne Karydas
53 2023
3 years
 Independent None stated COMPASS Pathways plc $307,043
Glenn P. Sblendorio
Board chair
 70 2023
3 years
 Independent
Audit Committee
Amicus Therapeutics, Inc., 4D Molecular Therapeutics, Inc. $331,310
Derek DiRocco
45 2022
4 years
 Independent
Compensation Committee
Evommune, Inc., Acrivon Therapeutics, Inc. Not stated
Jon Congleton
CEO
 62 2020
6 years
 Not stated None stated None stated Paid as CEO
Alexander Gold
60 2024
2 years
 Independent None stated None stated $305,276

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

Related-party transactions

No related-party transactions disclosed

The proxy filed Apr 8, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support
View Pricing Plans